ODI Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2019
Net Income	-0.72	-5.93	-0.57	-6.9	-7.24	-3.98	Upgrade
Depreciation & Amortization	0	0	0	0	0.01	0.01	Upgrade
Asset Writedown & Restructuring Costs	0	0	0	-	-	-	Upgrade
Other Operating Activities	0.43	0.9	0.1	0.91	0.04	-0.47	Upgrade
Change in Accounts Receivable	-1.8	9.98	-8.7	0.33	-0.35	-0.67	Upgrade
Change in Inventory	-	-	0.81	0.24	-0.49	-1.05	Upgrade
Change in Other Net Operating Assets	1.4	-8.26	4.53	0.31	0.65	0.1	Upgrade
Operating Cash Flow	-0.69	-3.31	-3.82	-5.1	-7.37	-6.06	Upgrade
Capital Expenditures	-	-	-	-	-0	-	Upgrade
Investing Cash Flow	-	-	-	-	-0	-	Upgrade
Long-Term Debt Issued	-	-	-	4.06	-	-	Upgrade
Net Debt Issued (Repaid)	-	-	-	4.06	-	-	Upgrade
Issuance of Common Stock	-	2.24	-	-	-	-	Upgrade
Other Financing Activities	0.34	-	-	-	-	0.26	Upgrade
Financing Cash Flow	0.34	2.24	-	4.06	-	0.26	Upgrade
Foreign Exchange Rate Adjustments	-0.26	-0.09	-0.02	0.16	0.12	-0.09	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-0	-0	-	-	Upgrade
Net Cash Flow	-0.61	-1.16	-3.85	-0.87	-7.26	-5.89	Upgrade
Free Cash Flow	-0.69	-3.31	-3.82	-5.1	-7.38	-6.06	Upgrade
Free Cash Flow Margin	-3.42%	-105.49%	-17.16%	-3659.83%	-2357.80%	-	Upgrade
Free Cash Flow Per Share	-0.03	-0.18	-0.25	-0.33	-0.49	-0.40	Upgrade
Cash Interest Paid	0.59	0.68	0.76	0.08	0	0.01	Upgrade
Cash Income Tax Paid	0	-0.09	0.09	-0.17	0.03	0.52	Upgrade
Levered Free Cash Flow	-2.66	-2.45	-3.54	1.5	-4.75	-4.6	Upgrade
Unlevered Free Cash Flow	-2.25	-1.99	-3.01	1.57	-4.73	-4.59	Upgrade
Change in Working Capital	-0.39	1.72	-3.36	0.88	-0.18	-1.62	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.